TRPC6 and diabetic kidney disease: Tetrandrine could alleviate podocyte injury induced by TRPC6 overexpression (43), decrease 24 h urine protein and glomerular cell proliferation in the membranous glomerulopathy (44), and restrain diabetic process and renal damage in diabetic nephropathy (45).